Kintara Therapeutics News

425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

May 14 17:00 ET

S-4: Registration of securities issued in business combination transactions

May 13 16:13 ET

425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Apr 25 09:09 ET

Kintara Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Apr 3 07:17 ET

Kintara Therapeutics | 424B5: Prospectus

Dec 18, 2023 16:05 ET

Kintara Therapeutics | 424B5: Prospectus

Sep 19, 2023 16:16 ET

Kintara Therapeutics | 424B5: Prospectus

Aug 3, 2022 09:07 ET

Kintara Therapeutics | 424B5: Prospectus

Apr 13, 2022 16:16 ET

Kintara Therapeutics | 424B5: Prospectus

Sep 27, 2021 17:28 ET

Kintara Therapeutics | EFFECT: Others

Apr 2, 2021 00:15 ET

Kintara Therapeutics | EFFECT: Others

Nov 5, 2020 00:15 ET

Kintara Therapeutics | 424B4: Prospectus

Nov 4, 2020 16:44 ET

Kintara Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Aug 18, 2020 08:41 ET

Kintara Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Aug 17, 2020 09:02 ET

Kintara Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jul 28, 2020 16:57 ET

Kintara Therapeutics | EFFECT: Others

Jul 6, 2020 00:15 ET

Kintara Therapeutics | 424B3: Prospectus

Jul 2, 2020 16:45 ET

Kintara Therapeutics | S-4/A: Registration of securities issued in business combination transactions (Amendment)

Jul 1, 2020 19:59 ET

Kintara Therapeutics | 425: Filing under Securities Act Rule 425 of certain prospectuses and communications in connection with business combination transactions

Jun 24, 2020 17:11 ET

Kintara Therapeutics | S-4: Registration of securities issued in business combination transactions

Jun 16, 2020 17:11 ET